| Dr Rahul Kapil, MD | |
|
Nemg Pulmonary Medicine - New London, 365 Montauk Avenue, 2nd Floor, Suite 2.006, New London, CT 06320 | |
| (860) 271-4309 | |
| Not Available |
| Full Name | Dr Rahul Kapil |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | Nemg Pulmonary Medicine - New London, New London, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336662196 | NPI | - | NPPES |
| Entity Name | Northeast Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043278351 PECOS PAC ID: 1254233836 Enrollment ID: O20040123000522 |
News Archive
Human immunodeficiency virus (HIV) superinfection may be as common as initial HIV infection and is not limited to high risk-populations, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health and the National Institute of Allergy and Infectious Diseases.
Nevro Corp., a medical device company focused on achieving improved pain relief for patients suffering from debilitating chronic pain, today announced that the U.S. Food and Drug Administration (FDA) has granted approval for initiation of its SENZA-RCT study, a U.S. prospective, randomized, controlled pivotal clinical trial evaluating the safety and efficacy of Nevro's high-frequency spinal cord stimulation system for the treatment of chronic pain.
In patients receiving therapeutic hypothermia after suffering out-of-hospital cardiac arrest, those who were cooled below 31 degrees Celsius (about 88 degrees Fahrenheit) for 24 hours showed no difference in terms of death or poor neurological outcomes at six months compared with patients receiving guideline-recommended cooling of 34 C (about 93 F).
Patients whose immune system responded to a peptide vaccine for leukemia enjoyed a median remission that was more than three times longer than non-responders, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
Using a synthetic peptide modeled after the protein that the human immunodeficiency virus (HIV) uses to enter cells, a multi-institutional research team has created quantum dots that can penetrate the cell membrane and image internal structures in a cell.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rahul Kapil, MD 267 Grant Street, Med Ed Podium 4, Bridgeport, CT 06610-0120 Ph: (203) 384-3883 | Dr Rahul Kapil, MD Nemg Pulmonary Medicine - New London, 365 Montauk Avenue, 2nd Floor, Suite 2.006, New London, CT 06320 Ph: (860) 271-4309 |
News Archive
Human immunodeficiency virus (HIV) superinfection may be as common as initial HIV infection and is not limited to high risk-populations, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health and the National Institute of Allergy and Infectious Diseases.
Nevro Corp., a medical device company focused on achieving improved pain relief for patients suffering from debilitating chronic pain, today announced that the U.S. Food and Drug Administration (FDA) has granted approval for initiation of its SENZA-RCT study, a U.S. prospective, randomized, controlled pivotal clinical trial evaluating the safety and efficacy of Nevro's high-frequency spinal cord stimulation system for the treatment of chronic pain.
In patients receiving therapeutic hypothermia after suffering out-of-hospital cardiac arrest, those who were cooled below 31 degrees Celsius (about 88 degrees Fahrenheit) for 24 hours showed no difference in terms of death or poor neurological outcomes at six months compared with patients receiving guideline-recommended cooling of 34 C (about 93 F).
Patients whose immune system responded to a peptide vaccine for leukemia enjoyed a median remission that was more than three times longer than non-responders, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
Using a synthetic peptide modeled after the protein that the human immunodeficiency virus (HIV) uses to enter cells, a multi-institutional research team has created quantum dots that can penetrate the cell membrane and image internal structures in a cell.
› Verified 2 days ago
Yardley Brice, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 365 Montauk Ave, New London, CT 06320 Phone: 860-442-0711 | |
Dr. Pradnya Velankar, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 365 Montauk Ave, New London, CT 06320 Phone: 860-442-0711 | |
Mical S Campbell, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: Coastal Digestive Diseases, 234a Bank St, New London, CT 06320 Phone: 860-442-0290 Fax: 860-442-2136 | |
Suzanne J Klekotka, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 155 Montauk Ave, New London, CT 06320 Phone: 860-444-2223 Fax: 860-440-3153 | |
Dr. John Edward Madsen, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 234a Bank St, New London, CT 06320 Phone: 860-442-0290 Fax: 860-442-2136 | |
Robert J Keltner, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 155 Montauk Avenue, New London, CT 06320 Phone: 860-444-2223 Fax: 860-440-3153 | |
Dr. Nicolas J Astras, DO Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 365 Montauk Ave, New London, CT 06320 Phone: 860-442-0711 |